Hypervascular Tumors clinical trials at University of California Health
2 in progress, 1 open to eligible people
Showing trials for
Instylla HES Hypervascular Tumor Pivotal Study
open to eligible people ages 22 years and up
To determine whether Instylla HES has the ability to effectively embolize targeted arterial segments of hypervascular tumors as well as (i.e., is non-inferior to) standard of care (SOC) transarterial embolization/conventional transarterial chemoembolization, while resulting in an acceptable risk of device and procedure-related serious adverse events.
at UC Irvine UCLA
An Observational Study of Radial Access Embolization Procedures Using HydroPearl Microspheres
Sorry, in progress, not accepting new patients
This registry study is designed to collect data on the procedural success and complication rates in real-world patients undergoing HydroPearl embolization procedures via radial access.
at UCLA
Last updated: